Robin Sherrington
Corporate Officer/Principal at XENON PHARMACEUTICALS INC.
Net worth: 336 760 $ as of 29/04/2024
Profile
Robin Sherrington currently works at Xenon Pharmaceuticals, Inc., as Executive Vice President-Strategy & Innovation from 2019.
Dr. Sherrington also formerly worked at Pfizer Inc., as Neuroscience Director from 1999 to 2001, Sequana Therapeutics, Inc., as Neuroscience Director from 1996 to 1999, Axys Pharmaceuticals, Inc., as Neuroscience Director from 1996 to 1999, and Parke-Davis & Co. Ltd., as Neuroscientist.
Dr. Sherrington received his undergraduate degree from The University of Reading and doctorate degree from University College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/03/2024 | 8,398 ( 0.01% ) | 336 760 $ | 29/04/2024 |
Robin Sherrington active positions
| Companies | Position | Start |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 28/02/2019 |
Former positions of Robin Sherrington
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 31/12/2000 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31/12/1998 |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Corporate Officer/Principal | 31/12/1998 |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Training of Robin Sherrington
| University College London | Doctorate Degree |
| The University of Reading | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Health Technology |
- Stock Market
- Insiders
- Robin Sherrington
